Crossmark

Characteristics and outcomes of patients with endometriosis and malignant or borderline ovarian tumors: real-world evidence from an ESGO centre of excellence

Crossref DOI link: https://doi.org/10.1186/s12885-026-15980-w

Published Online: 2026-04-16

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Beck, Maximilian Heinz https://orcid.org/0000-0002-0400-0046
Kordowitzki, Paul

Roser, Eva

Trelinska-Finger, Anna

Schoof, Emily

Chinczewski, Lukas

Mechsner, Sylvia

Sehouli, Jalid
Funding

Funding for this research was provided by:

Charité - Universitätsmedizin Berlin
License Information

Text and Data Mining valid from 2026-04-16

Version of Record valid from 2026-04-17
More Information

Article History

Received: 7 March 2026

Accepted: 2 April 2026

First Online: 16 April 2026

Declarations

:

: The study was approved by the local institutional ethics committee of Charité–Universitätsmedizin Berlin, Berlin, Germany (Vote EA2/266/22) and conducted in accordance with the Declaration of Helsinki. The institutional ethics committee of Charité–Universitätsmedizin Berlin (Vote EA2/266/22) waived the requirement for written informed consent.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below